Global Human Papilloma Virus (HPV) Screening Kits Market Growth 2025-2031

The global Human Papilloma Virus (HPV) Screening Kits market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Human Papilloma Virus (HPV) Screening is a test for cervical cancer, but it does not tell if you have cancer, it detects the presence of HPV (the virus that causes cervical cancer) in your system. Certain HPVs increase the risk of cervical cancer. Knowing whether you have a certain type of HPV, which increases the risk of cervical cancer, means patients and doctors can make better decisions about the next steps in treatment.

United States market for Human Papilloma Virus (HPV) Screening Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Human Papilloma Virus (HPV) Screening Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Human Papilloma Virus (HPV) Screening Kits is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Human Papilloma Virus (HPV) Screening Kits players cover Roche Diagnostics, QIAGEN, Thermo Fisher Scientific, Abbott, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Human Papilloma Virus (HPV) Screening Kits Industry Forecast” looks at past sales and reviews total world Human Papilloma Virus (HPV) Screening Kits sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Papilloma Virus (HPV) Screening Kits sales for 2025 through 2031. With Human Papilloma Virus (HPV) Screening Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Papilloma Virus (HPV) Screening Kits industry.

This Insight Report provides a comprehensive analysis of the global Human Papilloma Virus (HPV) Screening Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Papilloma Virus (HPV) Screening Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Papilloma Virus (HPV) Screening Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Papilloma Virus (HPV) Screening Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Papilloma Virus (HPV) Screening Kits.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Papilloma Virus (HPV) Screening Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
15 Below
15-20
20 Above

Segmentation by Application:
Hospital
Clinic
Third-party Testing Agency
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
QIAGEN
Thermo Fisher Scientific
Abbott
BD
Hologic
Cepheid
Bio-rad
Seegene
bioMérieux
Hybribio
Daan Gene
BGI Group
Shanghai ZJ Bio-tech
Taipu Bioscience
Tellgen Corporation
Orient Gene Biotech
Shenzhen Yaneng Biological Technology
Jiangsu Bioperfectus Technologies
Xiamen Zhishan Biological Technology
ACON Laboratories
National Bio-founder Biotech
Sansure Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Papilloma Virus (HPV) Screening Kits market?

What factors are driving Human Papilloma Virus (HPV) Screening Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Papilloma Virus (HPV) Screening Kits market opportunities vary by end market size?

How does Human Papilloma Virus (HPV) Screening Kits break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.